Access Restriction

Author Abou Chebl, Alex
Source SpringerLink
Content type Text
Publisher Springer-Verlag
File Format PDF
Copyright Year ©2011
Language English
Subject Domain (in DDC) Technology ♦ Medicine & health
Subject Keyword Endovascular ♦ Catheter ♦ Intra-arterial ♦ Mechanical clot disruption ♦ Intervention ♦ Thrombolysis ♦ Recanalization ♦ Reperfusion ♦ MERCI ♦ Penumbra ♦ Neurosurgery ♦ Neurology ♦ Neurosciences ♦ Neurobiology
Abstract Intra-arterial therapy (IAT) for acute ischemic stroke refers to endovascular catheter-based approaches to achieve recanalization using mechanical clot disruption, locally injected thrombolytic agents or both. IAT may be used in addition to intravenous tissue plasminogen activator (tPA) or in patients who do not qualify for tPA, usually because they are outside the approved 3-h timeframe window or have contraindications, such as elevated international normalized ratio or partial thromboplastin time. Recanalization rates correlate with clinical improvement, and with the newest catheters it is possible to achieve recanalization in roughly 80% of patients treated. However, while the catheters are approved by the Food and Drug Administration, there are still no randomized trial data demonstrating the role of current IAT therapy vs either tPA or standard management. IAT is reserved for patients with large artery occlusions in the basilar, distal carotid, or proximal middle cerebral arteries. Imaging the penumbra using magnetic resonance imaging or computed tomographic perfusion is currently the most frequently used way to identify patients who might benefit. However, the imaging and clinical criteria for identifying which patients benefit, and perhaps more importantly those who will do poorly despite IAT, remain unclear.
ISSN 19337213
Age Range 18 to 22 years ♦ above 22 year
Educational Use Research
Education Level UG and PG
Learning Resource Type Article
Publisher Date 2011-06-30
Publisher Institution American Society for Experimental NeuroTherapeutics
Publisher Place New York
e-ISSN 18787479
Journal NeuroRX
Volume Number 8
Issue Number 3
Page Count 14
Starting Page 400
Ending Page 413

Open content in new tab

   Open content in new tab
Source: SpringerLink